In glioblastoma, FAP has been proven to promote tumor growth and invasion via hydrolysis of molecules such as brevican in the extracellular matrix and targeting downstream pathways and substrates, such as fibroblast growth factor 21 (FGF21) [72]. The gene discussed is FAP; the disease is neoplasm.